ADVIA CENTAUR® IRI
Mexico·Clase I·III. DIAGNOSTIC AGENTS·SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.·Registered April 11, 2019REACTIVO PARA USO COMO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUANTITATIVA DE LA INSULINA EN SUERO CON LOS SISTEMAS ADVIA CENTAUR.
REAGENT FOR USE AS IN VITRO DIAGNOSTICS IN THE QUANTITATIVE DETERMINATION OF SERUM INSULIN WITH ADVIA CENTAUR SYSTEMS.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACIÓN DE INSULINA
- Trade Name (English)
- REAGENT FOR INSULIN DETERMINATION
- Analysis ID
- 760R2019 SSA
- Registration Date
- April 11, 2019
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for ADVIA CENTAUR® IRI (ADVIA CENTAUR® IRI) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 760R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on April 11, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.